|
|
REFERENCES
1.
2 Kings 4:33–35, King James Version.
2.
National Academy of Sciences National Research Council:
Cardiopulmonary resuscitation. JAMA 198:373, 1966.
3.
American Heart Association and the National Academy
of Sciences National Research Council: Standards for cardiopulmonary resuscitation
(CPR) and emergency cardiac care (ECC). JAMA 227(Suppl):833, 1974.
4.
American Heart Association: Standards and guidelines
for cardiopulmonary resuscitation (CPR) and emergency cardiac care (ECC). JAMA 244(Suppl):453,
1980.
5.
American Heart Association: Standards and guidelines
for cardiopulmonary resuscitation and emergency cardiac care. JAMA 255(Suppl):2841,
1986.
6.
American Heart Association Emergency Cardiac Care
Committee and Subcommittees: Guidelines for cardiopulmonary resuscitation and emergency
cardiac care. JAMA 268:2135, 1992.
7.
Emergency Cardiac Care Committee and Subcommittees,
American Heart Association: Proceedings of the 1992 National Conference on Cardiopulmonary
Resuscitation and Emergency Cardiac Care. Ann Emerg Med 22:275, 1993.
8.
American Heart Association in collaboration with
International Liaison Committee on Resuscitation: Guidelines 2000 for Cardiopulmonary
Resuscitation and Emergency Cardiovascular Care: International Consensus on Science,
Parts 1–12. Circulation 102(Suppl I):I–1, 2000.
9.
American Heart Association: Basic Life Support
for Healthcare Providers. Dallas, American Heart Association, 2000.
10.
Elam JO, Greene DG, Schneider MA, et al: Head-tilt
method of oral resuscitation. JAMA 172:812, 1960.
11.
Greene DG, Elam JO, Dobkin AB, et al: Cinefluorographic
study of hyperextension of the neck and upper airway patency. JAMA 176:570, 1961.
12.
Boidin MP: Airway patency in the unconscious patient.
Br J Anaesth 57:306, 1985.
13.
Safar P: Recognition and management of airway
obstruction. JAMA 208:1008, 1969.
14.
Ruben H, Knudsen EJ, Carugati G: Gastric inflation
in relation to airway pressure. Acta Anaesthesiol Scand 5:107, 1961.
15.
Wenzel V, Idris AH, Banner MJ, et al: Respiratory
system compliance decreases after cardiopulmonary resuscitation and stomach inflation:
Impact of large and small tidal volumes on calculated peak airway pressure. Resuscitation
38:113, 1998.
16.
Berg MD, Idris AH, Berg RA: Severe ventilatory
compromise due to gastric distension during cardiopulmonary resuscitation. Resuscitation
36:71, 1998.
17.
Hee MKJ, Plevak DJ, Peters SG: Intubation of critically
ill patients. Mayo Clin Proc 67:569, 1992.
18.
Kern KB, Halperin HR, Field J: New guidelines
for cardiopulmonary resuscitation and emergency cardiac care: Changes in the management
of cardiac arrest. JAMA 285:1267, 2001.
19.
Frass M, Frenzer R, Rauscha F, et al: Evaluation
of esophageal tracheal Combitube in cardiopulmonary resuscitation. Crit Care Med
15:609, 1986.
20.
Pepe PE, Zachariah BS, Chandra NC: Invasive airway
techniques in resuscitation. Ann Emerg Med 22:393, 1993.
21.
International Consensus on Science: Guidelines
2000 for cardiopulmonary resuscitation and emergency cardiovascular care: International
Consensus on Science. Circulation 102(Suppl):I–98, 2000.
22.
Wee MYK: The oesophageal detector device: Assessment
of a new method to distinguish oesophageal from tracheal intubation. Anaesthesia
43:27, 1988.
23.
Zaleski L, Abello D, Gold MI: The esophageal detector
device: Does it work? Anesthesiology 79:244, 1993.
24.
Salem MR, Wafai Y, Joseph NJ, et al: Efficacy
of the self-inflating bulb in detecting esophageal intubation: Does the presence
of a nasogastric tube or cuff deflation make a difference? Anesthesiology 80:42,
1994.
25.
Salem MR, Wafai Y, Baraka A, et al: Use of the
self-inflating bulb for detecting esophageal intubation after "esophageal ventilation."
Anesth Analg 77:1227, 1993.
26.
Wafai R, Salem MR, Baraka A: Effectiveness of
the self-inflating bulb for verification of proper placement of the esophageal tracheal
Combitube. Anesth Analg 80:122, 1995.
27.
Bozeman WP, Hexter D, Liang HK, et al: Esophageal
detector device versus detection of end-tidal carbon dioxide level in emergency intubation.
Ann Emerg Med 27:595, 1996.
28.
Czinn EA, Wafai Y, Salem MR, et al: Efficacy of
the self-inflating bulb for confirmation of emergency tracheal intubation in critically
ill patients. Anesthesiology 83:A266, 1995.
29.
Lang DJ, Wafai Y, Salem R, et al: Efficacy of
the self-inflating bulb in confirming tracheal intubation in the morbidly obese.
Anesthesiology 85:246, 1996.
30.
Reed AP: Current concepts in airway management
for cardiopulmonary resuscitation. Mayo Clin Proc 70:1172, 1995.
31.
Brimacombe J, Berry A, Verghese C: The laryngeal
mask airway in critical care medicine. Intensive Care Med 21:361, 1995.
32.
Sasada MP, Gabbott DA: The role of the laryngeal
mask airway in pre-hospital care. Resuscitation 28:97, 1994.
33.
Samarkandi AH, Seraj MA, El Dawlatly A, et al:
The role of laryngeal mask airway in cardiopulmonary resuscitation. Resuscitation
28:103, 1994.
34.
Bailey AR, Hett DA: The laryngeal mask airway
in resuscitation. Resuscitation 28:107, 1994.
35.
Devitt JH, Wenstone R, Noel AG, et al: The laryngeal
mask airway and positive-pressure ventilation. Anesthesiology 80:550, 1994.
36.
Kokkinis K: The use of the laryngeal mask airway
in CPR. Resuscitation 27:9, 1994.
37.
Alexander R, Hodgson P, Lomax D: A comparison
of laryngeal mask airway and Guedel airway, bag and facemask for manual ventilation.
Anaesthesia 48:231, 1993.
38.
Butler BD, Little T: Combined use of the esophageal-tracheal
Combitube with a colorimetric carbon dioxide detector for emergency intubation/ventilation.
Clin Monit 11:311, 1995.
39.
Benumof JL: Management of the difficult adult
airway. Anesthesiology 75:1087, 1991.
40.
Benumof JL, Scheller MS: The importance of transtracheal
jet ventilation in the management of the difficult airway. Anesthesiology 71:769,
1989.
41.
Deshmukh HG, Weil MH, Gudipati CV, et al: Mechanism
of blood flow generated by precordial compression during CPR. I. Studies on closed
chest precordial compression. Chest 95:1092, 1989.
42.
Higano ST, Oh JK, Ewy GA, et al: The mechanism
of blood flow during closed chest cardiac massage in humans: Transesophageal echocardiographic
observations. Mayo Clin Proc 65:1432, 1990.
43.
Kuhn C, Juchems R, Frese W: Evidence for the "cardiac
pump theory" in cardiopulmonary resuscitation in man by transesophageal echocardiography.
Resuscitation 22:275, 1991.
44.
Redberg RF, Tucker KJ, Cohen TJ, et al: Physiology
of blood flow during cardiopulmonary resuscitation: A transesophageal echocardiographic
study. Circulation 88:534, 1993.
45.
Harada Y, Fuseno H, Ohtomo T, et al: Self-administered
hyperventilation cardiopulmonary resuscitation for 100 s of cardiac arrest during
Holter monitoring. Chest 99:1310, 1991.
46.
Criley JM, Niemann JT, Rosborough JP, et al: Modifications
of cardiopulmonary resuscitation based on the cough. Circulation 74(Suppl IV):IV–42,
1986.
47.
Halperin HR, Chandra NC, Levin HR, et al: Newer
methods of improving blood flow during CPR. Ann Emerg Med 27:553, 1996.
48.
Cohen JM, Chandra N, Alderson PO, et al: Timing
of pulmonary and systemic blood flow during intermittent high intrathoracic pressure
cardiopulmonary resuscitation in the dog. Am J Cardiol 49:1883, 1982.
49.
Einagle V, Bertrand F, Wise RA, et al: Interposed
abdominal compressions and carotid blood flow during cardiopulmonary resuscitation:
Support for a thoracoabdominal unit. Chest 93:1206, 1988.
50.
Lindner KH, Ahnefeld FW, Bowdler IM: Cardiopulmonary
resuscitation with interposed abdominal compression after asphyxial or fibrillatory
cardiac arrest in pigs. Anesthesiology 72:675, 1990.
51.
Sack JB, Kesselbrenner MB, Jarrad A: Interposed
abdominal compression-cardiopulmonary resuscitation and resuscitation outcome during
asystole and electromechanical dissociation. Circulation 86:1692, 1992.
52.
Orliaguet GA, Carli PA, Rozenberg A, et al: End-tidal
carbon dioxide during out-of-hospital cardiac arrest resuscitation: Comparison of
active compression-decompression and standard CPR. Ann Emerg Med 25:48, 1995.
53.
Schultz JJ, Coffeen P, Sweeney M, et al: Evaluation
of standard and active compression-decompression CPR in an acute human model of ventricular
fibrillation. Circulation 89:684, 1994.
54.
Tucker KJ, Galli F, Savitt MA, et al: Active compression-decompression
resuscitation: Effect on resuscitation success after in-hospital cardiac arrest.
J Am Coll Cardiol 24:201, 1994.
55.
Lurie KG, Shultz JJ, Callaham ML, et al: Evaluation
of active compression-decompression CPR in victims of out-of-hospital cardiac arrest.
JAMA 271:1405, 1994.
56.
Schwab TM, Callaham ML, Madsen CD, et al: A randomized
clinical trial of active compression-decompression CPR vs standard CPR in out-of-hospital
cardiac arrest in two cities. JAMA 273:1261, 1995.
57.
Luiz T, Ellinger K, Denz C: Active compression-decompression
cardiopulmonary resuscitation does not improve survival in patients with prehospital
cardiac arrest in a physician-manned emergency medical system. J Cardiothorac Vasc
Anesth 10:178, 1996.
58.
Stiell IG, Hebert PC, Wells GA, et al: The Ontario
trial of active compression-decompression cardiopulmonary resuscitation for in-hospital
and prehospital cardiac arrest. JAMA 275:1417, 1996.
59.
Beattie C, Guerci AD, Hall T, et al: Mechanisms
of blood flow during pneumatic vest cardiopulmonary resuscitation. J Appl Physiol
70:454, 1991.
60.
Halperin HR, Chandra NC, Levin HR, et al: Newer
methods of improving blood flow during CPR. Ann Emerg Med 27:553, 1996.
61.
Halperin HR, Tsitlik JE, Gelfand M, et al: A preliminary
study of cardiopulmonary resuscitation by circumferential compression of the chest
with use of a pneumatic vest. N Engl J Med 329:762, 1993.
62.
Hackl W, Simon P, Mauritz W, et al: Echocardiographic
assessment of mitral valve function during mechanical cardiopulmonary resuscitation
in pigs. Anesth Analg 70:350, 1990.
63.
Chandra NC: Mechanisms of blood flow during CPR.
Ann Emerg Med 22:281, 1993.
64.
Sobotka P, Gebert E: Effect of complete brain
ischaemia on pupillary changes. Acta Anaesthesiol Scand 16:112, 1972.
65.
Steen-Hanson JE, Hansen NN, Vaagenes P, et al:
Pupil size and light reactivity during cardiopulmonary resuscitation: A clinical
study. Crit Care Med 16:69, 1988.
66.
Ornato JP: Hemodynamic monitoring during CPR.
Ann Emerg Med 22:289, 1993.
67.
Kalenda Z: The capnogram as a guide to the efficacy
of cardiac massage. Resuscitation 6:259, 1978.
68.
Grundler WG, Weil MH, Bisera J, et al: Observations
on endtidal carbon dioxide during experimental cardiopulmonary arrest. Clin Res
32:672A, 1984.
69.
Trevino RP, Bisera J, Weil MH, et al: End-tidal
CO2
as a guide to successful cardiopulmonary resuscitation: A preliminary
report. Crit Care Med 13:910, 1985.
70.
Grundler W, Weil MH, Rackow EC: Arteriovenous
carbon dioxide and pH gradients during cardiac arrest. Circulation 74:1071, 1986.
71.
Sanders AB, Ewy GA, Bragg S, et al: Expired PCO2
as a prognostic indicator of successful resuscitation from cardiac arrest. Ann Emerg
Med 14:948, 1985.
72.
Sanders AB, Atlas M, Ewy GA, et al: Expired PCO2
as an index of coronary perfusion pressure. Am J Emerg Med 3:147, 1985.
73.
Gudipati CV, Weil MH, Bisera J, et al: Expired
carbon dioxide: A noninvasive monitor of cardiopulmonary resuscitation. Circulation
77:234, 1988.
74.
Garnett AR, Ornato JP, Gonzalez ER, et al: End-tidal
carbon dioxide monitoring during cardiopulmonary resuscitation. JAMA 257:512, 1987.
75.
Sanders AB, Kern KB, Otto CW, et al: End-tidal
carbon dioxide monitoring during cardiopulmonary resuscitation: A prognostic indicator
for survival. JAMA 262:1347, 1989.
76.
Falk JL, Rackow EC, Weil MH: End-tidal carbon
dioxide concentration during cardiopulmonary resuscitation. N Engl J Med 318:607,
1988.
77.
Callaham M, Barton C: Prediction of outcome of
cardiopulmonary resuscitation from end-tidal carbon dioxide concentration. Crit
Care Med 18:358, 1990.
78.
Steedman DJ, Robertson CE: Measurement of end-tidal
carbon dioxide concentration during cardiopulmonary resuscitation. Arch Emerg Med
7:129, 1990.
79.
Asplin BA, White RD: Prognostic value of end-tidal
carbon dioxide pressures during out-of-hospital cardiac arrest. Ann Emerg Med 25:756,
1995.
80.
Wayne MA, Levine RL, Miller CC: Use of end-tidal
carbon dioxide to predict outcome in prehospital cardiac arrest. Ann Emerg Med 25:762,
1995.
81.
Isserles SA, Breen PH: Can changes in end-tidal
PCO2
measure changes in cardiac output?
Anesth Analg 73:808, 1991.
82.
Shibutani K, Muraoka M, Shirasaki S, et al: Do
changes in end-tidal PCO2
quantitatively
reflect changes in cardiac output? Anesth Analg 79:829, 1994.
83.
Trillo G, von Planta M, Kette F: ET
CO2
monitoring during low flow states: Clinical aims and limits. Resuscitation 27:1,
1994.
84.
Idris AH: End-tidal carbon dioxide physiology
and monitoring during resuscitation. Anesthesiol Clin North Am 13:785, 1995.
85.
Diack AW, Welborn WS, Rullman RG, et al: An automatic
cardiac resuscitator for emergency treatment of cardiac arrest. Med Instrum 13:78,
1979.
86.
Bardy GH, Zaghi H, Gartman D, et al: A prospective
randomized comparison of defibrillation efficacy of truncated pulses and damped sine
wave pulses in humans. J Cardiovasc Electrophysiol 5:725, 1994.
87.
Bardy GH, Gliner BE, Kudenchuk PJ, et al: Truncated
biphasic pulses for transthoracic defibrillation. Circulation 91:1768, 1995.
88.
Bardy GH, Marchlinski FE, Sharma AD, et al: Multi-center
comparison of truncated biphasic shocks and standard damped sine wave monophasic
shocks for transthoracic ventricular defibrillation. Transthoracic Investigators.
Circulation 94:2507, 1996.
89.
Schneider T, Martens PR, Paschen J, et al: Multi-center,
randomized, controlled trial comparing 150-J biphasic shocks and 200 to 360-joule
monophasic shocks in the resuscitation of out-of-hospital cardiac arrest victims.
Circulation 102:1780, 2000.
90.
Cummins RO, Hazinski MF, Kerber RE, et al: Low
energy biphasic waveform defibrillation: Evidence-based review applied to emergency
cardiovascular care guidelines. Circulation 97:1654, 1998.
91.
White RD, Hankins DG, Atkinson EJ: Patient outcomes
following defibrillation with a low energy biphasic truncated exponential waveform
in out-of-hospital cardiac arrest. Resuscitation 49:9, 2001.
92.
White RD: Early out-of-hospital experience with
an impedance-compensating low-energy biphasic waveform automatic external defibrillator.
J Intervent Card Electrophysiol 1:203, 1997.
93.
Biboulet P, Aubas, Dobourdieu J, et al: Fatal
and non-fatal cardiac arrests related to anesthesia. Can J Anaesth 48:326, 2001.
94.
Newland MC, Ellis SJ, Lydiatt CA, et al: Anesthetic-related
cardiac arrest and its mortality: A report covering 72,959 anesthetics over 10 years
from a US teaching hospital. Anesthesiology 97:108, 2002.
95.
Caplan RA, Ward RJ, Posner K, et al: Unexpected
cardiac arrest during spinal anesthesia: A closed claims analysis of predisposing
factors. Anesthesiology 68:5, 1988.
96.
Keats AS: Anesthesia mortality: A new mechanism.
Anesthesiology 68:2, 1988.
97.
Schwid HA, O'Donnell DO: Anesthesiologists' management
of simulated critical incidents. Anesthesiology 76:495, 1992.
98.
White RD: Pharmacologic management of arrhythmias
during advanced cardiac life support. Anesthesiol Clin North Am 13:849, 1995.
99.
Mackey DC, Carpenter RL, Thompson GE, et al: Bradycardia
and asystole during spinal anesthesia: A report of three cases without morbidity.
Anesthesiology 70:866, 1989.
100.
Gonzalez ER: Pharmacologic controversies in CPR.
Ann Emerg Med 22:317, 1993.
101.
Brown DL, Carpenter RL, Moore DC, et al: Cardiac
arrest during spinal anesthesia. III. Anesthesiology 68:971, 1988.
102.
Falk RH, Zoll PM, Zoll RH: Safety and efficacy
of noninvasive cardiac pacing: A preliminary report. N Engl J Med 309:1166, 1983.
103.
Berliner D, Okun M, Peters RW, et al: Transcutaneous
temporary pacing in the operating room. JAMA 254:84, 1985.
104.
Smith I, Monk TG, White PF: Comparison of transesophageal
atrial pacing with anticholinergic drugs for the treatment of intraoperative bradycardia.
Anesth Analg 78:245, 1994.
105.
Atlee JL 3d, Pattison CZ, Mathews EL, et al:
Transesophageal atrial pacing for intraoperative sinus bradycardia or AV junctional
rhythm: Feasibility as prophylaxis in 200 anesthetized adults and hemodynamic effects
of treatment. J Cardiothorac Vasc Anesth 7:436, 1993.
106.
Rankin AC, Brooks R, Ruskin JN, et al: Adenosine
and the treatment of supraventricular tachycardia. Am J Med 92:655, 1992.
107.
Camm AJ, Garratt CJ: Adenosine and supraventricular
tachycardia. N Engl J Med 325:1621, 1991.
108.
DiMarco JP, Sellers TD, Lerman BB, et al: Diagnostic
and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias.
J Am Coll Cardiol 6:417, 1985.
109.
DiMarco JP, Sellers TD, Berne RM, et al: Adenosine:
Electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular
tachycardia. Circulation 68:1254, 1983.
110.
Belardinelli L, Linden J, Berne RM: The cardiac
effects of adenosine. Prog Cardiovasc Dis 32:73, 1989.
111.
Lerman BB, Belardinelli L: Cardiac electrophysiology
of adenosine: Basic and clinical concepts. Circulation 83:1499, 1991.
112.
Rankin AC, Oldroyd KG, Chong E, et al: Value
and limitations of adenosine in the diagnosis and treatment of narrow and broad complex
tachycardias. Br Heart J 62:195, 1989.
113.
Griffith MJ, Linker NJ, Ward DE, et al: Adenosine
in the diagnosis of broad complex tachycardia. Lancet 1:672, 1988.
114.
Sharma AD, Klein GJ, Yee R: Intravenous adenosine
triphosphate during wide QRS complex tachycardia: Safety, therapeutic efficacy,
and diagnostic utility. Am J Med 88:337, 1990.
115.
McIntosh-Yellin NL, Drew BJ, Scheinman MM: Safety
and efficacy of central intravenous bolus administration of adenosine for termination
of supraventricular tachycardia. J Am Coll Cardiol 22:741, 1993.
116.
White RD: Acceleration of the ventricular response
in paroxysmal lone atrial fibrillation following the injection of adenosine. Am
J Emerg Med 11:245, 1993.
117.
Slade AKB, Garratt CJ: Proarrhythmic effect of
adenosine in a patient with atrial flutter. Br Heart J 70:91, 1993.
118.
Brodsky MA, Allen BJ, Grimes JA, et al: Enhanced
atrioventricular conduction during atrial flutter after intravenous adenosine. N
Engl J Med 330:288, 1994.
119.
Brodsky MA, Hwang C, Hunter D, et al: Life-threatening
alterations in heart rate after the use of adenosine in atrial flutter. Am Heart
J 130:564, 1995.
120.
Shen W-K, Kurachi Y: Mechanisms of adenosine-mediated
actions on cellular and clinical cardiac electrophysiology. Mayo Clin Proc 70:274,
1995.
121.
Lerman BB, Wesley RC, Belardinelli L: Electrophysiologic
effects of dipyridamole on atrioventricular nodal conduction and supraventricular
tachycardia: Role of endogenous adenosine. Circulation 80:1536, 1989.
122.
German DC, Kredich NM, Bjornsson TD: Oral dipyridamole
increases plasma adenosine levels in human beings. Clin Pharmacol Ther 45:80, 1989.
123.
DeGroff CG, Silka MJ: Bronchospasm after intravenous
administration of adenosine in a patient with asthma. J Pediatr 125:822, 1994.
124.
Drake I, Routledge PA, Richards R: Bronchospasm
induced by intravenous adenosine. Hum Exp Toxicol 13:263, 1994.
125.
Bennett-Guerrero E, Young CC: Bronchospasm after
intravenous adenosine administration. Anesth Analg 79:386, 1994.
126.
Aggarwal A, Farber NE, Warltier DC: Intraoperative
bronchospasm caused by adenosine. Anesthesiology 79:1132, 1993.
127.
Waxman HL, Myerburg RJ, Appel R, et al: Verapamil
for control of ventricular rate in paroxysmal supraventricular tachycardia and atrial
fibrillation or flutter: A double-blind randomized cross-over study. Ann Intern
Med 94:1, 1981.
128.
McGovern B, Garan H, Ruskin JN: Precipitation
of cardiac arrest by verapamil in patients with Wolff-Parkinson-White syndrome.
Ann Intern Med 104:791, 1986.
129.
Gulamhusein S, Ko P, Carruthers SG, et al: Acceleration
of the ventricular response during atrial fibrillation in the Wolff-Parkinson-White
syndrome after verapamil. Circulation 65:348, 1982.
130.
Garratt C, Antoniou A, Ward D, et al: Misuse
of verapamil in preexcited atrial fibrillation. Lancet 1:367, 1989.
131.
Stambler BS, Wood MA, Ellenbogen KA, et al: Efficacy
and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial
flutter or fibrillation. Circulation 94:1613, 1996.
132.
Stambler BS, Beckman KF, Kadish AH, et al: Acute
hemodynamic effects of intravenous ibutilide in patients with or without reduced
left ventricular function. Am J Cardiol 80:458, 1997.
133.
Scher DL, Arsura EL: Multifocal atrial tachycardia:
Mechanisms, clinical correlates, and treatment. Am Heart J 118:574, 1989.
134.
Varriale P, David W, Chryssos BE: Multifocal
atrial arrhythmia—a frequent misdiagnosis? A correlative study using the computerized
ECG. Clin Cardiol 15:343, 1992.
135.
Schwartz M, Rodman D, Lowenstein SR: Recognition
and treatment of multifocal atrial tachycardia: A critical review. J Emerg Med
12:353, 1994.
136.
White RD: Prehospital recognition of multifocal
atrial tachycardia: Association with acute myocardial infarction. Ann Emerg Med
21:753, 1992.
137.
Strickberger SA, Miller CB, Levine JH: Multifocal
atrial tachycardia from electrolyte imbalance. Am Heart J 115:680, 1988.
138.
Naccarelli GV, Jalal S: Intravenous amiodarone:
Another option in the acute management of sustained ventricular tachyarrhythmias.
Circulation 92:3154, 1995.
139.
Kowey PR, Levine JH, Herre JM, et al: Randomized,
double-blind comparison of intravenous amiodarone and bretylium in the treatment
of patients with recurrent, hemodynamically destabilizing ventricular tachycardia
or fibrillation. Circulation 92:3255, 1995.
140.
Schienman MM, Levine JH, Cannom DS, et al: Dose-ranging
study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias.
Circulation 92:3264, 1995.
141.
Levine JH, Massumi A, Scheinman MM, et al: Intravenous
amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. J Am
Coll Cardiol 27:67, 1996.
142.
Dessertenne F, Fabiato A, Coumel P: A new chapter
of electrocardiography: The progressive variations in the amplitude of the electrocardiogram.
Cardiovasc Drugs Ther 5:171, 1991.
143.
Dessertenne F, Coumel P, Fabiato A: Ventricular
fibrillation and torsades de pointes. Cardiovasc Drugs Ther 4:1177, 1990.
144.
Priori SG, Napolitano C, Schwartz PJ: Electrophysiologic
mechanisms involved in the development of torsades de pointes. Cardiovasc Drugs
Ther 5:203, 1991.
145.
Napolitano C, Priori SG, Schwartz PJ: Torsades
de pointes: Mechanisms and management. Drugs 47:51, 1994.
146.
Tan HL, Hou CJY, Lauer MR, et al: Electrophysiologic
mechanisms of the long QT interval syndromes and torsades de pointes. Ann Intern
Med 122:701, 1995.
147.
Kay GN, Plumb VJ, Arciniegas JG, et al: Torsades
de pointes: The long-short initiating sequence and other clinical features: Observations
in 32 patients. J Am Coll Cardiol 2:806, 1983.
148.
Hohnloser SH, Klingenheben T, Singh BN: Amiodarone-associated
proarrhythmic effects: A review with special reference to torsades de pointes tachycardia.
Ann Intern Med 121:529, 1994.
149.
Nguyen PT, Scheinman MM, Seger J: Polymorphous
ventricular tachycardia: Clinical characterization, therapy, and the QT interval.
Circulation 74:340, 1986.
150.
Soffer J, Dreifus LS, Michelson EL: Polymorphous
ventricular tachycardia associated with normal and long Q-T intervals. Am J Cardiol
49:2021, 1982.